NEWS HIGHLIGHTSMedia Articles Related to Teveten (Eprosartan)
Seasoning May Cut Salt Needs in Hypertension (CME/CE)
Source: MedPage Today Primary Care [2013.05.18]
SAN FRANCISCO (MedPage Today) -- A greater taste for salt among older hypertensive adults might be sated by seasoning instead, a small experimental study showed.
Surprising Findings On Hypertension In Adolescents
Source: Hypertension News From Medical News Today [2013.05.07]
Teenagers with high blood pressure appear to have better psychological adjustment and enjoy higher quality of life than those with normal blood pressure, suggests a study in the May issue of Psychosomatic Medicine: Journal of Biobehavioral Medicine, the official journal of the American Psychosomatic Society...
Safety-Net Clinics Face Challenges Controlling Hypertension In Their Patients
Source: Hypertension News From Medical News Today [2013.04.19]
Federally funded safety-net clinics for the uninsured lag behind other health care providers in controlling blood pressure among the low-income patients who rely on them for care, a new Michigan State University analysis suggests...
Relationship Between Obesity, Heart Disease And Hypertension
Source: Hypertension News From Medical News Today [2013.04.13]
Obesity, heart disease, and high blood pressure (hypertension) are all related, but understanding the molecular pathways that underlie cause and effect is complicated...
Preeclampsia (Pregnancy Induced Hypertension)
Source: MedicineNet Hydronephrosis Specialty [2012.05.21]
Title: Preeclampsia (Pregnancy Induced Hypertension)
Category: Diseases and Conditions
Created: 11/14/1998 4:06:00 PM
Last Editorial Review: 5/21/2012 12:00:00 AM
Published Studies Related to Teveten (Eprosartan)
Effects of eprosartan on diastolic function and neurohormones in patients with hypertension and diastolic dysfunction. [2010.02]
OBJECTIVE: To compare the effects of an angiotensin receptor blocker(ARB)-based regimen versus a non-ARB based regimen on diastolic function and neurohormones in patients with hypertension and diastolic dysfunction... CONCLUSION: Lowering blood pressure, either with eprosartan or other anti-hypertensives in hypertensive patients with diastolic dysfunction did not change diastolic function after 6 months of treatment, but was associated with a decrease of NT-proBNP.
Comparative effects of telmisartan and eprosartan on insulin sensitivity in the treatment of overweight hypertensive patients. [2009.12]
The aim of this study was to compare the effect of telmisartan and eprosartan on insulin sensitivity in overweight hypertensive patients. Fifty overweight (BMI > or = 25 and <30 kg/m (2)) outpatients, aged 41-65 years, with mild to moderate hypertension [systolic blood pressure (SBP) >140 and diastolic blood pressure (DBP) > or = 90 and < or = 110 mmHg], after a 4-week placebo period, were randomized to receive telmisartan 80 mg or eprosartan 600 mg for 8 weeks...
Eprosartan in the primary prevention of cardiac allograft vascular disease: a double-blind prospectively randomized study using intravascular ultrasound. [2008.09]
The angiotensin blocker (ARB) eprosartan (600 mg once daily) and the calcium antagonist diltiazem (90 mg twice daily) were studied in a 24-month prospective, randomized, double-blind trial involving 53 heart transplant patients. The study compared their effects on the development of post-transplant cardiac allograft vasculopathy, a condition that frequently impairs long-term post-transplantation survival and where angiotensin blockers might be expected to play a preventive role...
Effect of eprosartan on the sympathetic response to cold pressor test in healthy volunteers. [2006.06.30]
The aim of this study was to evaluate the effect of short-term administration of the AT1 angiotensin II receptor antagonist, eprosartan, on the sympathetic response to cold pressor test (CPT) in normotensive healthy volunteers. Sixty-nine healthy volunteers were included in this double-blind placebo-controlled study...
Atenolol and eprosartan: differential effects on central blood pressure and aortic pulse wave velocity. [2006.02]
BACKGROUND: Recent data suggest that atenolol may be inferior to other antihypertensive drugs in reducing cardiovascular risk in older individuals with hypertension, despite lowering peripheral blood pressure (BP). We hypothesized that that atenolol fails to reduce central BP as much as other agents. The aim of the present study was to compare the hemodynamic effects of atenolol and eprosartan in a double-blind, randomized, cross-over study... CONCLUSIONS: These data indicate that despite similar effects on peripheral BP and a greater effect on aortic stiffness, atenolol had less impact on central systolic BP than eprosartan because it failed to reduce wave reflection. This provides one potential explanation for the failure of atenolol to improve outcome in older patients with essential hypertension.
Clinical Trials Related to Teveten (Eprosartan)
Comparison of the Effect of Eprosartan and Eprosartan Mesylate on Blood Pressure in Essential Hypertension [Recruiting]
Aim of this study is to compare the blood pressure lowering effect of a new drug formulation
of eprosartan. Eprosartan belongs to a class of blood pressure lowering agents used
worldwide since years with proven efficacy. The new formulation is compared to the currently
marketed eprosartan tablet. Equivalent efficacy in blood pressure lowering effects should be
demonstrated.
Observational Study to Investigate Resistant Hypertension Prevalence in Korean General Hospitals [Not yet recruiting]
Study Objectives The study is to identify prevalence, demography and clinical
characteristics of patients with resistant hypertension among hypertensive patients who have
been treated in general hospitals in Korea from Jan 2012 to Jun 2012.
- Diagnosis of resistant hypertension: In case of clinic blood pressure exceeding the
boundary of systolic blood pressure at 140mmHg and diastolic blood pressure at 90mmHg
(hereinafter refer to as 140/90mmHg) (130/80mmHg for patients with diabetes mellitus or
chronic renal disease) despite triple antihypertensive therapy at optimal dose may be
diagnosed as resistant hypertension. Antihypertensive medications used include
diuretics. Resistant hypertension may also be diagnosed when clinic blood pressure has
reached the target value but quadruple or more of antihypertensives are used.
- Diagnosis of controlled hypertension: Patients whose clinic blood pressure equals to
140/90mmHg (130/80mmHg for patients with diabetes mellitus or chronic renal disease) or
less with the administration of antihypertensives at optimal dose may be diagnosed as
controlled hypertension.
The Effect of Eprosartan on Hormones and Kidney Function in Healthy Humans. [Completed]
We, the investigators at Holstebro Hospital, want to test the hypothesis that eprosartan
reduces the activity of the sympathetic nervous system in healthy individuals - during
baseline conditions and after activation of the sympathetic nervous system.
The Effect of Eprosartan on Hormones and Kidney Function in Patients With Essential Hypertension [Completed]
We, the investigators at Holstebro Hospital, want to test the hypothesis that eprosartan
reduces the activity of the sympathetic nervous system in patients with essential
hypertension - during baseline conditions and after activation of the sympathetic nervous
system.
Comparison of Eprosartan/HCT Versus Enalapril/HCT in Hypertensives With Type II Diabetes [Completed]
|
